STAT reporters reached out to key figures in biotech, pharma, and medical devices to find out what they think about President-elect Trump’s pick of Johns Hopkins pancreatic surgeon Martin “Marty” Makary as commissioner of the Food and Drug Administration.

Makary, a vocal critic of the federal government’s response to Covid-19, would oversee the federal agency charged with approving all new drugs.

Martin A. Makary, MD, of Johns Hopkins University, a critic of vaccination schedules and COVID-19 measures promulgated by public health leaders, has been named by President-Elect Donald Trump as his nominee for commissioner of the FDA.